New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 11, 2012
10:21 EDTAU, SWN, RRC, QEP, LIFE, IPI, IPCI, HMY, GFI, COG, BMY, YELPOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AngloGold (AU) initiated with an Outperform at Credit Suisse... Bristol-Myers (BMY) reinstated with a Neutral at Credit Suisse... Cabot Oil & Gas (COG) initiated with an Outperform at Bernstein... Gold Fields (GFI) initiated with a Neutral at Credit Suisse... Harmony Gold (HMY) initiated with an Underperform at Credit Suisse... Intellipharmaceutics (IPCI) initiated with a Buy at Brean Murray... Intrepid Potash (IPI) initiated with a Buy at Wunderlich... Life Technologies (LIFE) initiated with a Buy at WallachBeth... QEP Resources (QEP) initiated with an Outperform at BMO Capital... Range Resources (RRC) initiated with an Outperform at Bernstein... Southwestern Energy (SWN) initiated with an Outperform at Bernstein... Yelp (YELP) initiated with a Neutral at Piper Jaffray.
News For AU;BMY;COG;GFI;HMY;IPCI;IPI;LIFE;QEP;RRC;SWN;YELP From The Last 14 Days
Check below for free stories on AU;BMY;COG;GFI;HMY;IPCI;IPI;LIFE;QEP;RRC;SWN;YELP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
July 24, 2014
08:28 EDTBMYBristol-Myers management to meet with JPMorgan
Subscribe for More Information
07:44 EDTCOGCabot Oil & Gas reports Q2 Marcellus Shale averaged 1,258 Mmcf per day
Subscribe for More Information
07:43 EDTCOGCabot Oil & Gas reports Q2 production of 127.6 Bcfe
Reports Q2 liquids production of 961,000 barrels, an increase of 26% over last year's comparable quarter as reported; Reports Q2 crude oil and condensate production of 869,000 barrels, an increase of 25% over last year's comparable quarter as reported; Natural gas price realizations, including the effect of hedges, were $3.47 per thousand cubic feet in Q2. the impact of hedges, natural gas price realizations for the quarter were $3.78 per Mcf. Total per unit costs decreased to $2.59 per Mcfe in the second quarter of 2014, down 16 percent from $3.10 per Mcfe in the second quarter of 2013.
07:42 EDTCOGCabot Oil & Gas reports Q2 adjusted EPS 28c, consensus 25c
Subscribe for More Information
07:32 EDTBMYBristol-Myers reaffirms 2014 EPS outlook $1.70-$1.80, consensus $1.77
Subscribe for More Information
07:31 EDTBMYBristol-Myers reports Q2 EPS 48c, consensus 44c
Reports Q2 revenue $ $3.89B, consensus $3.85B.
07:13 EDTYELPYelp August volatility elevated into Q2 and growth outlook
Subscribe for More Information
05:26 EDTBMYBristol-Myers, Ono Pharmaceutical announces strategic collaboration in Japan
Bristol-Myers Squibb and Ono Pharmaceutical have signed a strategic collaboration agreement to jointly develop and commercialize multiple immunotherapies as single agents and combination regimens to help address the unmet medical needs of patients with cancer in Japan, South Korea and Taiwan. As part of the agreement, Bristol-Myers Squibb and Ono will jointly develop and commercialize Opdivo and Yervoy across a broad range of tumor types. Bristol-Myers Squibb and Ono will jointly pursue development of monotherapy and combination regimens, with Opdivo as the foundational therapy in Japan, South Korea and Taiwan, and leverage global clinical trials by including patients from the three countries.
July 23, 2014
18:34 EDTYELPOn The Fly: After Hours Movers
UP AFTER EARNINGS: Fortinet (FTNT), up 7.8%... Hanesbrands (HBI), up 5.4%... 8x8 (EGHT), up 5.1%... Infinera (INFN), up 4.9%... Facebook (FB), reverses and is now trading up 5.1% following second quarter earnings conference call. NOTABLE: Twitter (TWTR), up 1.7%, LinkedIn (LNKD), up marginally, and Yelp (YELP), up 1.6% after Facebook reports second quarter results. ALSO HIGHER: Spectranetics (SPNC), up 7.1% after receiving FDA clearance for atherectomy products, Turbo-Tandem and Turbo Elite... Ariad Pharmaceuticals (ARIA), up 7.1%... Jamba (JMBA), up 3.8% after Engaged Capital reports stake in the company and announced that they had discussions with management. DOWN AFTER EARNINGS: AT&T (T), down 1.2%... Angie's List (ANGI), down 16.4%... Tripadvisor (TRIP), down 11.5%... Orchids Paper (TIS), down 7.4%... Cirrus Logic (CRUS), down 6.6%... Cliffs Natural (CLF), down 1.2%... Teradyne (TER), down 4%. ALSO LOWER: Kandi Technologies (KNDI), down 3.8% after being mentioned negatively in a Seeking Alpha blog post.
15:30 EDTBMYNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Ford (F), consensus 36c; General Motors (GM), consensus 58c; Potash (POT), consensus 46c; Caterpillar (CAT), consensus $1.52; 3M (MMM), consensus $1.91; Union Pacific (UNP), consensus $1.43; Bristol-Myers Squibb (BMY), consensus 44c; Eli Lilly (LLY), consensus 65c; Celgene (CELG), consensus 89c; Precision Castparts (PCP), consensus $3.35; Raytheon (RTN), consensus $1.59; Noble Energy (NBL), consensus 79c; Hershey (HSY), consensus 76c; Southwest Airlines (LUV), consensus 61c; Boston Scientific (BSX), consensus 19c; JetBlue (JBLU), consensus 19c.
15:10 EDTBMYBristol-Myers technical comments before earnings
Subscribe for More Information
10:02 EDTRRCOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:57 EDTIPCIIntellipharmaceutics management to meet with Brean Capital
Subscribe for More Information
08:15 EDTCOGCabot Oil & Gas price target lowered to $43 from $52 at RW Baird
Subscribe for More Information
07:45 EDTRRCRange Resources upgraded to Overweight from Equal Weight at Stephens
Subscribe for More Information
July 22, 2014
09:47 EDTYELPYelp initiated with a Neutral at Tigress Financial
July 21, 2014
06:43 EDTBMYGrowing market for hepatitis-C treatment prompts legal scramble, WSJ says
Subscribe for More Information
July 17, 2014
10:00 EDTCOGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:08 EDTCOGCabot Oil & Gas initiated with a Market Perform at FBR Capital
Subscribe for More Information
08:08 EDTBMYBristol-Myers, Pfizer announce enrollment in Phase IV EMANATE trial for Eliquis
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use